*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.
In an estimated $30-million deal, Pennsylvania healthcare comms agency Cadient Group is to be acquired by tech consultancy Cognizant.
Cadient is being acquired by consultancy Cognizant; Valeant ups the ante in Allergan bid; BMS settles Sustiva patent suits; Americans are dying at a lesser rate; Stricter Ebola screening at ...
The acquisition is meant to bolster the WPP agency's payer and market-access capabilities.